Jones Erin's Form 4/A amendment
AmendedGritstone bio, Inc. (GRTS) · filed Nov 19, 2021
- Accession no.
- 0001567619-21-020888
- Filed
- Nov 19, 2021, 6:01 PM ET
- Trade date
- Sep 8, 2021
- Filing delay
- 72 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Sep 10, 2021
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $22.7K. It was filed 72 days after the trade.
This amendment replaces 0001567619-21-016965 (filed Sep 10, 2021).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jones ErinCIK 0001754278 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2021 | Common Stock | MOption exerciseAcquired | +2,000 | $0.345 | +$690 | 47,900 | Direct | |
| Sep 8, 2021 | Common Stock | SSaleDisposed | −2,000 | $11.37 | −$22,747.6 | 45,900 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2021 | Common Stock | MOption exerciseDisposed | −2,000 | $0.00 | $0 | 35,971 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction.
- F2
Includes 25,900 Restricted Stock Units which are subject to vesting.
- F3
Fully exercisable.
Remarks
Executive Vice President, Global Regulatory Affairs and Quality